X
X
Leaving Community
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
No
Yes
Welcome to Data Science Corner Virtual Booth
NIDDK Data Science Corner Program Presentation Schedule
June 5, 2026 (Fri)
| Time Slot | Location | Program | Session Type | Presentation Title | Presenter |
|---|---|---|---|---|---|
| 12:45-1:45 pm CT | 1031-OR | CMDKP | Oral Presentation | Identifying Diabetes-Relevant Gene Programs across Metabolic Tissues in the Common Metabolic Diseases Knowledge Portal (Part of Session: Human Islet Cell Identity and Organization) | Dr. Julie Jurgens |
| 12:45-1:45 pm CT | 355 (Level 3) | PanKbase | Oral Presentation | Spatial Organization of Human Islet Endocrine Cells Modulates Stimulated Hormone Secretion (Part of Session: Human Islet Cell Identity and Organization) | Dr. Fan Feng |
| 12:45-1:45 pm CT | 245 (Level 2) | TrialNet | Oral Presentation | ADA Presidents' Select Abstract: Time to Minimal Residual C-Peptide as an Efficacy Measure in Recent-Onset Type 1 Diabetes Immunotherapy Trials [Part of Session: Beyond A1C: New Ways to Measure Disease Progression in Early-Stage Type 1 Diabetes?” (With ADA Presidents’ Select Abstract Presentation)] | Dr. Samuel Wu |
| 12:45-1:45 pm CT | 245 (Level 2) | TrialNet | Oral Presentation | Increase in Insulin Clearance Features Rapid Disease Progression in Children with Preclinical Type 1 Diabetes (T1D) [Part of Session: Beyond A1C: New Ways to Measure Disease Progression in Early-Stage Type 1 Diabetes?” (With ADA Presidents’ Select Abstract Presentation)] | Dr. Alfonso Galderisi |
| 2:30-3:30 pm CT | R07 (Level 2) | PanKbase | Oral Presentation | 1083-OR Multiomic Dissection of Human Pancreatic Islet Responses to Inflammatory and Viral Stimuli Reveals Cell-Type–Specific Regulatory Dynamics Relevant to Type 1 Diabetes (Part of Session: Multiomic Approaches and Resources for Providing Insights into Diabetes Pathophysiology) | Dr. Cassie Robertson |
| 2:30-3:30 pm CT | R07 (Level 2) | PanKbase | Oral Presentation | 1084-OR PanKbase Integrated Pancreatic Islet Single-Cell Map: A Comprehensive Resourcewith New Insights into Diabetes (Part of Session: Multiomic Approaches and Resources for Providing Insights into Diabetes Pathophysiology) | Dr. Ha Vu |
| 6:30-8:30 pm CT | Exhibit Hall (NIDDK Data Science Corner) #2312 #2318 #2320 #2322 #2324 #2326 #2333 | All programs | Networking | NIDDK Data Science Corner @ADA Networking Reception | Exhibitors |
June 6, 2026 (Sat)
| Time Slot | Location | Program | Session Type | Presentation Title | Presenter |
|---|---|---|---|---|---|
| 8:00-8:20 am CT | 355 (Level 3) | HIRN/nPOD | Oral Presentation | Diabetes from Within: Beyond Immune Infiltration to Comprehensive Pathology in 600 Human Pancreata | Dr. John Kaddis |
| 8:00-8:20 am CT | R05 (Level 2) | RADIANT | Oral Presentation | Metabolomic Subtypes of Atypical Diabetes (Part of Symposium, Using Genetics to Elucidate Atypical Diabetes) | Dr. Klara Klein |
| 8:20-8:40 am CT | R05 (Level 2) | RADIANT | Oral Presentation | Metabolomic Subtypes of Atypical Diabetes (Part of Symposium, Using Genetics to Elucidate Atypical Diabetes) | Dr. Akshay Bareja |
| 8:40-9:00 am CT | R05 (Level 2) | RADIANT | Oral Presentation | Polygenic Risk Scores Aid in Understanding Heterogeneity or Patients with Atypical Diabetes (Part of Symposium, Using Genetics to Elucidate Atypical Diabetes) | Dr. Raymond Kreienkamp |
| 9:00-9:20 am CT | R05 (Level 2) | RADIANT | Oral Presentation | SMAD5 as an Etiologic Link between Ovarian Pathology and Diabetes in PCOS (Part of Symposium, Using Genetics to Elucidate Atypical Diabetes) | Dr. Tessa Steenwinkel |
| 8:00-9:00 am CT | 343 (level3) | PanKbase | Oral Presentation | Genomics of immune responses in the pancreas in type 1 diabetes (Part of Symposium: Harnessing Big Data to Decode Immune Mechanisms in Type 1 Diabetes) | Dr. Kyle Gaulton |
| 12:30-1:30 pm CT | ePoster Theater 2097-P | TrialNet | ePoster | Age at T1D Diagnosis is an Independent Risk Factor from HLA for Development of T1D in First-Degree Relatives | Dr. Gregory Power |
| 12:30-1:30 pm CT | Poster Hall 2223-P | TrialNet | Poster | Harnessing Machine Learning to Forecast Two-Year Progression to Stage 3 Type 1 Diabetes (T1D) in Individuals with Multiple Type 1 Diabetes Autoantibodies: A Noise-Resistant, Multidimensional Clustering Approach | Dr. Erin Tallon |
| 12:30-1:30 pm CT | Poster Hall 2382-P | TrialNet | Poster | Modeling B-Cell Decline Across Preclinical T1D | Dr. Alice Carr |
| 12:30-1:30 pm CT | Poster Hall 2385-P | TrialNet | Poster | Insulin-Independent Glucose Elevation Contributes to Hyperglycemia in Autoantibody-Positive Stage 3 Type 1 Diabetes with a Type 2 Diabetes-Like Clinical Phenotype | Dr. Maria J. Redondo |
| 2:30-2:45 pm CT | La Nouvelle Orleans B (Level 2) | TrialNet | Oral Presentatio | Lifestyle Changes (LC) among Participants in Trials of Disease Modifying Therapies (DMT) in Type 1 Diabetes (T1D) (Part of Session: Contemporary and Emerging Diabetes Technologies and Therapies: Psychosocial and Behavioral Considerations) | Dr. Christine March |
| 4:30-6:00 pm CT | 356 (Level 3) | PanKbase | Oral Presentation | Human Islets Studies Are Also Critical and Complementary (Part of Session: Why Would We Do Away with the Mouse? Animal and Human Research Are Complementary!) | Dr. Marcela Brissova |
| 4:50-5:10 pm CT | 355 (Level 3) | TrialNet | Oral Presentation | Disease-Modifying Therapies vs. Islet-Cell Replacement in Pediatric Type 1 Diabetes (Part of Symposium: Beta-Cell Replacement in Pediatric Type 1 Diabetes: Promise and Perspective) | Dr. Laura Jacobsen |
June 7, 2026 (Sun)
| Time Slot | Location | Program | Session Type | Presentation Title | Presenter |
|---|---|---|---|---|---|
| 8:00-9:30 am CT | La Nouvelle Orleans C (Level 2) | NIDDK | Oral Presentation | Symposium - Rising Minds: AI Innovations in Diabetes—NIDDK Early-Career Investigator Symposium | Moderators: Drs. Shuibing Chen and Xujing Wang |
| 9:00-9:20 am CT | La Nouvelle Orleans B (Level 2) | TrialNet | Oral Presentation | TOPPLE T1D (TN27) Trial Results (Part of Symposium: Emerging Insights from T1D immunotherapy Clinical Trials) | Dr. Robin Goland |
| 12:30-1:30 pm CT | Poster Hall 3024-LB | TrialNet | Poster | T Stem Cell Memory Levels in Relation to Progression and Treatment Response across Stages of Type 1 Diabetes | Dr. Matthew Dufort |
| 2:15-2:30 pm CT | Hall E-3 (Level 1) | dkNET | Oral Presentation | Risk Prediction (Part of Session: Ask the Expert - AI and Innovation for Clinical Health Care Delivery in DM) | Dr. Wei Wang |
| 4:40-5:00 pm CT | La Nouvelle Orleans C (Level 2) | TrialNet | Oral Presentation | Update on the Cure for Type 1 Diabetes (Part of Symposium: 2026 ADA State of Type 1 Diabetes) | Dr. Laura Jacobsen |
June 8, 2026 (Mon)
| Time Slot | Location | Program | Session Type | Presentation Title | Presenter |
|---|---|---|---|---|---|
| 12:30-1:30 pm CT | Poster Hall 2097-P | TrialNet | Poster | Age at T1D Diagnosis is an Independent Risk Factor from HLA for Development of T1D in First-Degree Relatives | Dr. Gregory Power |
| 12:30-1:30 pm CT | Poster Hall 2391-P | TrialNet | Poster | Combination of Electrochemiluminescence-Based Autoantibodies and Genetic Risk Scores Enhances Type 1 Diabetes Prediction in Single-Antibody Positive Individuals | Dr. Liping Yu |
| 12:30-1:30 pm CT | Poster Hall 2395-P | PanKbase | Poster | PanKgraph: An Integrated Knowledge Graph for Type 1 Diabetes Research | Dr. Yiqun Wang |